The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
Of all the skin-care and cosmetics products I recently bought online that turned out to be counterfeit, expired, used, or otherwise problematic, the one that still makes me squirm is a curiously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results